Target intelligence / Profile preview

Human organic anion transporter 1 and Human organic anion transporter 3 (OAT1 and OAT3)

Target
OAT1 and OAT3
Molecular classification
Transporter, Solute carrier family (Major Facilitator Superfamily, SLC22), Transmembrane protein
01

Overview

The **human organic anion transporter 1 (OAT1, SLC22A6)** and **human organic anion transporter 3 (OAT3, SLC22A8)** are closely related **membrane transporters** in the kidney, belonging to the solute carrier (SLC22) family[1][3][5]. Both proteins are primarily expressed at the basolateral membrane of proximal tubular cells, where they mediate the uptake of a broad spectrum of endogenous and exogenous organic anions from the blood into renal epithelial cells as the first step in renal secretion and drug elimination[1][3][5]. They operate mainly via an *organic anion–α-ketoglutarate exchange mechanism*, enabling secondary active transport of anionic drugs, toxins, and metabolic waste products[2][3][5]. OAT1/OAT3 are targets for drug-drug interactions (notably inhibition by probenecid), and play important roles in the pharmacokinetics and potential nephrotoxicity of various clinical drugs, especially antivirals (tenofovir, adefovir, cidofovir)[3][4][5]. Dysfunction or pharmacological inhibition of these transporters is implicated in altered drug disposition, toxicity, and disease states such as chronic kidney disease and uremia[3][5]. Structural studies, including recent cryo-EM data, reveal that these proteins operate through complex conformational changes characteristic of the Major Facilitator Superfamily, supporting alternating access of substrates across the membrane[4][5].

Other names
Organic anion transporter 1SLC22A6New Kidney Transporter (NKT)Organic anion transporter 3SLC22A8Organic anion transporter family
02

Mechanism of action

Drugs inhibiting OAT1/OAT3: Block renal secretion of target drugs/metabolites, leading to increased plasma levels (e.g., probenecid blocks secretion of uric acid and drug substrates) Drugs utilizing OAT1/OAT3 for elimination: Rely on active transport into renal tubular cells (e.g., tenofovir, adefovir), followed by excretion into urine Exchange mechanism: Secondary active transport via organic anion/dicarboxylate exchanger (primarily α-ketoglutarate)

03

Biological functions

Transport of organic anions across the basolateral membrane of proximal tubular cells in kidneyRenal excretion of endogenous and exogenous compounds (toxins, metabolites, drugs)Transmembrane exchange of organic anions for dicarboxylates (usually α-ketoglutarate)Regulation of blood-urine homeostasis
04

Disease associations

Drug-induced nephrotoxicityChronic kidney diseaseGoutUremiaOther: Potential involvement in other drug-related toxicities or pharmacokinetics
05

Safety considerations

Drug-drug interactionsNephrotoxicityPolymorphismsAccumulation of toxins
06

Interacting drugs

Probenecid

6 more in the full profile.

07

Biomarkers

Not commonly used as routine clinical biomarkers; OAT1/OAT3 expression or function is studied experimentally as a marker for renal organic anion handling and nephrotoxicity riskTransport activity assaysCandidate pharmacogenomic markers for drug disposition variability

Beyond the preview

Go deeper on Human organic anion transporter 1 and Human organic anion transporter 3 (OAT1 and OAT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human organic anion transporter 1 and Human organic anion transporter 3 (OAT1 and OAT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call